{"componentChunkName":"component---src-templates-study-details-page-js","path":"/en/study/CCR104627","result":{"data":{"studyNotFoundJson":{"title":"Study not found","content":{"childMarkdownRemark":{"html":"<p>If you entered a web address please check it was correct.</p>\n<p>You can also try <a href=\"/en/studies\">Search Page</a> to find the study you are looking for.</p>"}}},"trialDetailsJson":{"title":"Details Page","returnSearch":"Back to search results","description":"Study Description","identifier":"ViiV Study ID","clinicalID":"Clinicaltrials.gov Identifier","EudraCtID":"EudraCT Number","resultsAvailable":"Has Results Available Below","docAvailable":"Has Results Document Available","studyOverview":"Study Overview","overviewSection":{"conditionsDisplay":"Medical Conditions","product":"Product","collaborators":"Collaborators","dates":"Date","studyType":"Type","phase":"Phase","gender":"Gender","age":"Age","acceptVolunteers":"Accepts Healthy Volunteers"},"studyDocuments":"Study Documents","noDocuments":"No documents available","studyDocumentsAdditionalText":"If you wish to request for Full Study Report, please contact - ","studyDocumentsAdditionalEmail":"GSKClinicalSupportHD@gsk.com","isReleased":{"firstPart":"This study has Protocol and Result summary on ClinicalTrial.gov. Click","secondPart":"to learn more.","linkText":"here"},"mapLocations":"Locations","centralContact":"Central Contact","centralPhone":"Central Contact Phone","centralEmail":"Central Contact Email","mapSection":{"site":"GSK Investigational Site","condition":"Condition","id":"Study ID","city":"City","state":"State","zip":"Zip","country":"Country"},"studyDesign":"Study Design","designSection":{"purpose":"Primary Purpose","allocation":"Allocation","study_design":"Study Design","study_classification":"Study Classification","masking":"Masking","masked_subject":"Masked Subject","masked_caregiver":"Masked Caregiver","masked_investigator":"Masked Investigator","masked_assessor":"Masked Assessor","primary_outcomes":"Primary Outcomes","secondary_outcomes":"Secondary Outcomes","arms":"Arms","interventions":"Interventions","keyword":"Keyword","inclusionTitle":"Inclusion Criteria","exclusionTitle":"Exclusion Criteria","criteriaText":"Inclusion/Exclusion Criteria","criteria_button":"Click to view inclusion/exclusion criteria","enrollment":"Enrollment","clinicalPublications":"Clinical Publications"},"popoversText":{"studyId":{"childMarkdownRemark":{"html":"<p>A unique number for a study given by ViiV.</p>"}},"ctGov":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the US clinicaltrials.gov register. Click this link to go to the entry for this study on Clinicaltrials.gov where you will be able to see protocol and results summaries where available.</p>"}},"eudraCT":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the EU clinicaltrials.eu register. Click this link to go to the entry for this study on clinicaltrials.eu where you will be able to see protocol and results summaries where available.</p>"}}}},"site":{"siteMetadata":{"siteUrl":"https://www.viiv-studyregister.com"}},"studyDetails":{"nct_number":"NCT00123890","ctis_id":"","HasResults":"false","IpdAccessCriteria":"","IpdDescription":"","IpdInfoTypeAnalyticCode":"","IpdInfoTypeIcf":"","IpdInfoTypeCsr":"","IpdInfoTypeProtocol":"","IpdInfoTypeSap":"","IpdTimeFrame":"","IpdUrl":"","IsFlexibleTrial":false,"IsReleasedToCtGov":"true","MaskingInfo":{"masked_assessor":"false","masked_caregiver":"false","masked_investigator":"false","masked_subject":"false","masking_description":"","no_masking":""},"PatientLevelData":"false","SharingIpd":"","acronym":"","allocation":"N/A","arm_groups":[],"assignment":"None","brief_summary":"The purpose of this study is to determine eligibility for one of three treatment studies of the CCR5 antagonist GW873140 or an observational study without GW873140. No investigational treatment will be administered through this study.","brief_summary_OneLinkTx":"","brief_title_OneLinkTx":"","brief_title":"Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140","conditions":[{"DisplayValue":"Human Immunodeficiency Virus (HIV)","DisplayValue_OneLinkTx":"","InternalValue":"CON_HIV","LookupValue":"HIV Infection","LookupValue_OneLinkTx":""}],"created_date":"09/15/2018 18:04:37","criteria":"Inclusion Criteria: - HIV-infected. - Screening viral load at least 5000copies/mL. - Total prior antiretroviral experience of at least 3 months and documented resistance to at least one drug in each of the following classes: nucleoside reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), and protease inhibitors (PI), stable antiretroviral regimen (or no antiretroviral treatment) for at least 4 weeks before screening. - Able to receive a ritonavir-boosted protease inhibitor during treatment studies. - Women of childbearing potential must use specific forms of contraception. Exclusion criteria: - Acute laboratory abnormalities. - History of pancreatitis or hepatitis, hepatitis B or hepatitis C coinfection, or any chronic liver disease. Screening liver function tests will be used to determine eligibility. - Changes to antiretroviral therapy from 4 weeks prior to screening until Day 1 of treatment or observational studies. - Pregnancy or breastfeeding women. - Recent participation in an experimental drug trial. - Prior use of a CCR5 or CXCR4 antagonist. - Significant ECG abnormalities or significant history of active pancreatitis, hepatitis, opportunistic infections, malabsorption disorders, cancer, or severe illness. - Current use of certain medications may exclude participation in this study. - Additional qualifying criteria and laboratory test requirements to be assessed by study physician.","detailed_description":"","display_gender":"Both","display_gender_internal":"GENDER_ALL","display_phase":"Phase 3","display_phase_internal":"PHASE_3","display_status":"Other","display_status_internal":"RECSTATUS_OTHER","endpoint":"","enrollment":"0","exclusion":"","gender":"Both","gender_based":"","gender_description":"","healthy_volunteers":"no","id":"c7a403bd-dbe4-5636-b516-d4e5acc4374c","internal":{"content":null,"contentDigest":"0056886eaea69ef853e304c91a1d6380","description":null,"fieldOwners":null,"mediaType":null,"ignoreType":null,"owner":"default-site-plugin","type":"studyDetails"},"inclusion":"Inclusion Criteria: - HIV-infected. - Screening viral load at least 5000copies/mL. - Total prior antiretroviral experience of at least 3 months and documented resistance to at least one drug in each of the following classes: nucleoside reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), and protease inhibitors (PI), stable antiretroviral regimen (or no antiretroviral treatment) for at least 4 weeks before screening. - Able to receive a ritonavir-boosted protease inhibitor during treatment studies. - Women of childbearing potential must use specific forms of contraception. Exclusion criteria: - Acute laboratory abnormalities. - History of pancreatitis or hepatitis, hepatitis B or hepatitis C coinfection, or any chronic liver disease. Screening liver function tests will be used to determine eligibility. - Changes to antiretroviral therapy from 4 weeks prior to screening until Day 1 of treatment or observational studies. - Pregnancy or breastfeeding women. - Recent participation in an experimental drug trial. - Prior use of a CCR5 or CXCR4 antagonist. - Significant ECG abnormalities or significant history of active pancreatitis, hepatitis, opportunistic infections, malabsorption disorders, cancer, or severe illness. - Current use of certain medications may exclude participation in this study. - Additional qualifying criteria and laboratory test requirements to be assessed by study physician.","interventions":[{"arm_group_label":"","intervention_description":"","intervention_name":"GW873140","intervention_type":"Drug"}],"interventional_subtype":"Diagnostic","is_fda_regulated":true,"is_high_value":false,"is_ind_study":true,"keywords":["HIV-1 GW873140 CCR5 antagonist experienced"],"last_follow_up_date":"10/01/2005 00:00:00","links":[],"locations":[{"City":"Houston","Latitude":"29.740582","CountryDisplay":"United States","Longitude":"-95.4515725","Name":"GSK Investigational Site","StateDisplay":"Texas","PostalCode":"77027","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Tucson","Latitude":"32.2625656","CountryDisplay":"United States","Longitude":"-111.1175767","Name":"GSK Investigational Site","StateDisplay":"Arizona","PostalCode":"85745","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Hollywood","Latitude":"26.0181766","CountryDisplay":"United States","Longitude":"-80.1596041","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33020","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Laguna Beach","Latitude":"33.5563145","CountryDisplay":"United States","Longitude":"-117.77252","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"92651","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Fort Lauderdale","Latitude":"26.1897731","CountryDisplay":"United States","Longitude":"-80.1037721","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33308","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Oakland Park","Latitude":"26.180392","CountryDisplay":"United States","Longitude":"-80.1372757","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33334","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Tampa","Latitude":"27.9717504","CountryDisplay":"United States","Longitude":"-82.4915194","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33607","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Oakland","Latitude":"37.8321173","CountryDisplay":"United States","Longitude":"-122.2625529","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"94609","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Newark","Latitude":"40.7350747","CountryDisplay":"United States","Longitude":"-74.1739057","Name":"GSK Investigational Site","StateDisplay":"New Jersey","PostalCode":"07102","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Dallas","Latitude":"32.7962048","CountryDisplay":"United States","Longitude":"-96.7694752","Name":"GSK Investigational Site","StateDisplay":"Texas","PostalCode":"75246","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Washington","Latitude":"38.9191485","CountryDisplay":"United States","Longitude":"-77.0362967","Name":"GSK Investigational Site","StateDisplay":"District of Columbia","PostalCode":"20009","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Orlando","Latitude":"28.5747416","CountryDisplay":"United States","Longitude":"-81.3949264","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"32804","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Glastonbury","Latitude":"41.7056381","CountryDisplay":"United States","Longitude":"-72.5559746","Name":"GSK Investigational Site","StateDisplay":"Connecticut","PostalCode":"06033","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Chicago","Latitude":"41.9403795","CountryDisplay":"United States","Longitude":"-87.6531805","Name":"GSK Investigational Site","StateDisplay":"Illinois","PostalCode":"60657","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Norwalk","Latitude":"41.1339818","CountryDisplay":"United States","Longitude":"-73.4062342","Name":"GSK Investigational Site","StateDisplay":"Connecticut","PostalCode":"06851","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Las Vegas","Latitude":"36.1462673","CountryDisplay":"United States","Longitude":"-115.1829873","Name":"GSK Investigational Site","StateDisplay":"Nevada","PostalCode":"89102","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"New Orleans","Latitude":"29.9510658","CountryDisplay":"United States","Longitude":"-90.0715323","Name":"GSK Investigational Site","StateDisplay":"Louisiana","PostalCode":"70127-0800","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Tarzana","Latitude":"34.1494848","CountryDisplay":"United States","Longitude":"-118.5506158","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"30342","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Portland","Latitude":"45.4618086","CountryDisplay":"United States","Longitude":"-122.7181903","Name":"GSK Investigational Site","StateDisplay":"Oregon","PostalCode":"97219","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Spokane","Latitude":"47.6457534","CountryDisplay":"United States","Longitude":"-117.4253653","Name":"GSK Investigational Site","StateDisplay":"Washington","PostalCode":"99204","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"New York","Latitude":"40.7366138","CountryDisplay":"United States","Longitude":"-74.0094471","Name":"GSK Investigational Site","StateDisplay":"New York","PostalCode":"10014","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Plantation","Latitude":"26.1218038","CountryDisplay":"United States","Longitude":"-80.2209773","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33317","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Koebenhavn","Latitude":"55.7085326","CountryDisplay":"Denmark","Longitude":"12.5727765","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"DK-2100","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Koeln","Latitude":"50.9096296","CountryDisplay":"Germany","Longitude":"6.9137713","Name":"GSK Investigational Site","StateDisplay":"Nordrhein-Westfalen","PostalCode":"50937","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Austin","Latitude":"30.2962208","CountryDisplay":"United States","Longitude":"-97.8299383","Name":"GSK Investigational Site","StateDisplay":"Texas","PostalCode":"78746","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Portland","Latitude":"45.5266975","CountryDisplay":"United States","Longitude":"-122.6880503","Name":"GSK Investigational Site","StateDisplay":"Oregon","PostalCode":"97209","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Boston","Latitude":"42.3476181","CountryDisplay":"United States","Longitude":"-71.1002881","Name":"GSK Investigational Site","StateDisplay":"Massachusetts","PostalCode":"02215","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"East Orange","Latitude":"40.7564795","CountryDisplay":"United States","Longitude":"-74.2208673","Name":"GSK Investigational Site","StateDisplay":"New Jersey","PostalCode":"07018","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Akron","Latitude":"41.0801473","CountryDisplay":"United States","Longitude":"-81.5020328","Name":"GSK Investigational Site","StateDisplay":"Ohio","PostalCode":"44304","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Atlanta","Latitude":"33.8676889","CountryDisplay":"United States","Longitude":"-84.4645184","Name":"GSK Investigational Site","StateDisplay":"Georgia","PostalCode":"30339","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Hampton","Latitude":"37.0538822","CountryDisplay":"United States","Longitude":"-76.3984537","Name":"GSK Investigational Site","StateDisplay":"Virginia","PostalCode":"23666","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Duesseldorf","Latitude":"51.1974375","CountryDisplay":"Germany","Longitude":"6.7898817","Name":"GSK Investigational Site","StateDisplay":"Nordrhein-Westfalen","PostalCode":"40225","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Hamburg","Latitude":"53.5580847","CountryDisplay":"Germany","Longitude":"10.011979","Name":"GSK Investigational Site","StateDisplay":"Hamburg","PostalCode":"20099","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Hannover","Latitude":"52.3763832","CountryDisplay":"Germany","Longitude":"9.8026933","Name":"GSK Investigational Site","StateDisplay":"Niedersachsen","PostalCode":"30625","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Lynchburg","Latitude":"37.4137536","CountryDisplay":"United States","Longitude":"-79.1422464","Name":"GSK Investigational Site","StateDisplay":"Virginia","PostalCode":"24501","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Long Beach","Latitude":"33.7844997","CountryDisplay":"United States","Longitude":"-118.1971031","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"90813","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Baltimore","Latitude":"39.2963369","CountryDisplay":"United States","Longitude":"-76.6210539","Name":"GSK Investigational Site","StateDisplay":"Maryland","PostalCode":"21201","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Minneapolis","Latitude":"44.9605503","CountryDisplay":"United States","Longitude":"-93.2616717","Name":"GSK Investigational Site","StateDisplay":"Minnesota","PostalCode":"55404","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Los Angeles","Latitude":"34.1147313","CountryDisplay":"United States","Longitude":"-118.3637264","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"90046","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Bruxelles","Latitude":"50.8427501","CountryDisplay":"Belgium","Longitude":"4.3515499","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"1000","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Charleroi","Latitude":"50.4169337","CountryDisplay":"Belgium","Longitude":"4.449552","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"6000","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Toronto","Latitude":"43.6622852","CountryDisplay":"Canada","Longitude":"-79.3790251","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"M5B 1L6","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"}],"masking":"Open Label","maximum_age_raw":"N/A N/A","maximum_age":"N/A","minimum_age":"18","minimum_age_raw":"18 Years","modified_date":"10/01/2018 23:02:16","number_of_arms":"1","observational_design":{"biospecimen_description":"","biospecimen_retention":"","number_of_groups":"","observational_study_design":"","patient_registry":"","target_duration_quantity":"","target_duration_units":"","timing":""},"official_title":"A screening protocol to determine eligibility for one of three Phase III treatment studies evaluating the efficacy and safety of GW873140 in R5-tropic and R5/X4-tropic HIV-1 infected, treatment-experienced subjects with drug-resistant virus or an observational study.","org_study_id":"CCR104627","overall_contact":{"email":null,"last_name":"US GSK Clinical Trials Call Center","phone":"877-379-3718"},"overall_status":"Terminated","oversight_info":{"exported_from_us":"","fda_regulated_device":"","fda_regulated_drug":"","ped_postmarket_surv":"","has_dmc":null,"post_prior_to_approval":"","regulatory_authorities":[""]},"phase":"Phase 3","primary_compl_date":"10/01/2005 00:00:00","primary_outcomes":[{"outcome_description":"","outcome_measure":"Determination of subject eligibility for CCR102709, CCR104456, CCR104458, or CCR104629.","outcome_time_frame":"","outcome_safety_issue":null}],"product_name":"","product_name_OneLinkTx":"","secondary_ids":[],"secondary_outcomes":[{"outcome_description":null,"outcome_measure":null,"outcome_time_frame":null,"outcome_safety_issue":null}],"sponsors":{"investigator_affiliation":"","investigator_username":"","lead_sponsor":"ViiV Healthcare","collaborators":[]},"start_date":"06/01/2005 00:00:00","study_type":"Interventional","therapeutic_area":"Infectious Diseases","citations":[],"is_section_801":true}},"pageContext":{"studyId":"CCR104627"}},"staticQueryHashes":["162689979","3332233851","3729204765","3769354840","399703114"]}